We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Intercell Completes Equity Private Placement of EUR 15.2 Million at a Price of EUR 2.30 Per New Share

News   May 15, 2012

 
Intercell Completes Equity Private Placement of EUR 15.2 Million at a Price of EUR 2.30 Per New Share
 
 
 

RELATED ARTICLES

Influenza Virus Molecules Set Immune Response Into Overdrive

News

Mini viral RNA plays a key role in the immune response that is triggered by influenza infections.

READ MORE

Pre-clinical Success Offers Hope for Universal Flu Vaccine

News

The identification of epitopes with limited variability offers a mechanism by which a universal vaccine can be created.

READ MORE

Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

News

Genetic data highlights the previously understated role CD4+ T cells and MHC-II molecules play in keeping cancer at bay.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE